← Scroll for more →
Financial Statements — MAZE
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 202.64 | 198.77 | 189.25 | 316.77 | 264.54 | 294.37 |
| Short-term Investments | 208.44 | 153.62 | 152.67 | 67.16 | -- | -- |
| Accounts Receivable | -- | 20.00 | -- | -- | -- | -- |
| Total Current Assets | 420.42 | 379.78 | 349.72 | 391.30 | 271.15 | 299.71 |
| Property, Plant & Equipment | 4.39 | 4.68 | 5.04 | 5.54 | 6.01 | 6.31 |
| Total Non-current Assets* | 111.20 | 39.93 | 47.41 | 30.76 | 32.37 | 33.13 |
| Total Assets | 531.63 | 419.71 | 397.13 | 422.06 | 303.52 | 332.84 |
| Accounts Payable | 2.21 | 4.01 | 1.79 | 2.92 | 3.67 | 2.40 |
| Total Current Liabilities | 22.96 | 21.24 | 22.56 | 22.11 | 19.90 | 18.62 |
| Long-term Debt | 38.96 | 38.83 | -- | -- | -- | -- |
| Total Non-current Liabilities* | 55.54 | 56.77 | 19.61 | 20.51 | 21.38 | 22.16 |
| Total Liabilities | 78.50 | 78.01 | 42.16 | 42.62 | 41.28 | 40.77 |
| Retained Earnings | (558.48) | (513.75) | (489.55) | (454.98) | (424.89) | (391.21) |
| Total Stockholder Equity | 453.12 | 341.70 | 354.97 | 379.44 | 262.24 | 292.07 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 20.00 | 0.00 | 2.50 | 0.00 | -- |
| Research & Development | 34.94 | 34.15 | 27.57 | 25.19 | 28.11 | 27.58 |
| Selling, General & Admin | 13.10 | 12.41 | 10.49 | 7.78 | 8.37 | 7.82 |
| Total Operating Expenses | 48.04 | 46.55 | 38.06 | 32.97 | 36.47 | 35.40 |
| Operating Income | (48.03) | (26.55) | (38.06) | (32.97) | (36.47) | (35.40) |
| Pretax Income | -- | -- | (34.57) | (30.09) | (33.68) | (32.79) |
| Tax Provision | -- | -- | 0.00 | 0.00 | 0.00 | -- |
| Net Income | (44.73) | (24.21) | (34.57) | (30.09) | (33.68) | (32.79) |
| Basic EPS | (0.76) | (0.45) | (0.47) | (0.66) | (0.77) | (1.15) |
| Diluted EPS | (0.76) | (0.45) | (0.47) | (0.66) | (0.77) | (1.15) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | (15.05) | (39.11) | (27.73) | (24.64) | (30.05) | (29.52) |
| Capital Expenditures | 0.11 | 0.09 | 0.03 | 0.07 | 0.39 | 0.30 |
| Free Cash Flow* | (15.16) | (39.21) | (27.76) | (24.71) | (30.44) | (29.81) |
| Investing Cash Flow | (128.51) | 6.28 | (103.39) | (66.88) | (0.39) | (0.30) |
| Financing Cash Flow | 147.44 | 42.36 | 3.59 | 143.76 | 0.61 | 127.38 |
← Scroll for more columns →
* Derived from reported values